Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 8, 2023
Distillery Therapeutics
An anti-citrullinated protein mAb with therapeutic effects in RA
BioCentury | Jan 26, 2019
Product Development
Target wide, test narrow in lupus
How the lupus field can springboard from its seven late-stage misses in 2018
BioCentury | Jun 15, 2015
Emerging Company Profile
Maximizing immunogenicity
Why OncoQR thinks its S-TIR vaccine can work better than other cancer vaccines
Items per page:
1 - 9 of 9